Aadi Bioscience, Inc.
Aadi Bioscience, Inc. (AADI) Revenue
Annual & quarterly revenue history · segment & region breakdown
AADI · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAadi Bioscience, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 72.50% year-over-year from $0.01B in FY2025.
Revenue trend
2025 – 2008 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.01B | -$0.02B | -72.50% |
| 2024-12-31 | $0.03B | +$0.00B | +6.69% |
| 2023-12-31 | $0.02B | +$0.01B | +60.06% |
| 2022-12-31 | $0.02B | +$0.01B | +1258.57% |
| 2021-12-31 | $0.00B | -$0.01B | -92.00% |
| 2020-12-31 | $0.01B | +$0.01B | +1769.16% |
| 2019-12-31 | $0.00B | -$0.02B | -96.28% |
| 2018-12-31 | $0.02B | +$0.02B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Aadi Bioscience, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Aadi Bioscience, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Aadi Bioscience, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AADI revenue · 4 questionsAADI's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 72.50% year-over-year from $0.01B in FY2025.
▸ Source: FMP · Aadi Bioscience, Inc. SEC filings · GAAP · Aadi Bioscience, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026